A detailed history of Private Management Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Private Management Group Inc holds 649 shares of LLY stock, worth $511,535. This represents 0.02% of its overall portfolio holdings.

Number of Shares
649
Previous 649 -0.0%
Holding current value
$511,535
Previous $587,000 2.21%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$724.87 - $909.04 $48,566 - $60,905
67 Added 11.51%
649 $587,000
Q3 2023

Oct 30, 2023

SELL
$434.7 - $599.3 $52,598 - $72,515
-121 Reduced 17.21%
582 $312,000
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $18,238 - $24,386
52 Added 7.99%
703 $329,000
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $4,659 - $5,472
-15 Reduced 2.25%
651 $223,000
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $185,634 - $217,961
666 New
666 $216,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Private Management Group Inc Portfolio

Follow Private Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Private Management Group Inc with notifications on news.